ArticleNature communications2025
Impact of a community-based antiretroviral therapy delivery model for people living with HIV in Cambodia.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cambodia achieved the UNAIDS 90-90-90 targets in 2017; however, clinic congestion, stigma, and mental health disparities continue to challenge sustained HIV care. This quasi-experimental study evaluated a community-based antiretroviral therapy delivery model compared with multi-month dispensing among people living with HIV across 20 clinics (N = 4,089) from 2021 to 2023. Baseline and endline surveys and clinical data assessed treatment adherence, viral suppression, retention in care, stigma, depressive symptoms, and quality of life. Both approaches achieved high retention in care (>97%) and viral suppression rates (>99%). The community-based model showed significantly improved adherence, reduced depressive symptoms, and higher physical health-related quality of life. Modest reductions in experienced stigma were observed, but effects on internalised and anticipated stigma were inconclusive. These findings indicate that community-based antiretroviral therapy delivery effectively sustains adherence and improves health outcomes, supporting its integration into Cambodia's HIV care system alongside interventions targeting stigma reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.